Table of Contents
ISRN Nanotechnology
Volume 2014 (2014), Article ID 951016, 8 pages
http://dx.doi.org/10.1155/2014/951016
Research Article

Factorial Design Studies and Biopharmaceutical Evaluation of Simvastatin Loaded Solid Lipid Nanoparticles for Improving the Oral Bioavailability

1University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh 522510, India
2A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India

Received 12 November 2013; Accepted 16 December 2013; Published 13 February 2014

Academic Editors: C. Li and S. Santra

Copyright © 2014 Kovoru Krishnam Raju et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Holm, H. Tønsberg, E. B. Jørgensen, P. Abedinpour, S. Farsad, and A. Müllertz, “Influence of bile on the absorption of halofantrine from lipid-based formulations,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 81, no. 2, pp. 281–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Hauss, S. E. Fogal, J. V. Ficorilli et al., “Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor,” Journal of Pharmaceutical Sciences, vol. 87, no. 2, pp. 164–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Swartz, “The physiology of the lymphatic system,” Advanced Drug Delivery Reviews, vol. 50, no. 1-2, pp. 3–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Delie, “Evaluation of nano- and microparticle uptake by the gastrointestinal tract,” Advanced Drug Delivery Reviews, vol. 34, no. 2-3, pp. 221–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Nishioka and H. Yoshino, “Lymphatic targeting with nanoparticulate system,” Advanced Drug Delivery Reviews, vol. 47, no. 1, pp. 55–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Cavalli, M. R. Gasco, P. Chetoni, S. Burgalassi, and M. F. Saettone, “Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin,” International Journal of Pharmaceutics, vol. 238, no. 1-2, pp. 241–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Olbrich, O. Kayser, and R. H. Müller, “Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage time and crystallinity,” International Journal of Pharmaceutics, vol. 237, no. 1-2, pp. 119–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Demirel, Y. Yazan, R. H. Müller, F. Kiliç, and B. Bozan, “Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles,” Journal of Microencapsulation, vol. 18, no. 3, pp. 359–371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Zhang, H. Bu, Z. Gao, Y. Huang, F. Gao, and Y. Li, “The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats,” International Journal of Pharmaceutics, vol. 394, no. 1-2, pp. 147–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Tiwari and K. Patha, “Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin:Comparative analysis lysof characteristics, pharmacokinetics and tissue uptake,” International Journal of Pharmaceutics, vol. 415, pp. 232–243, 2011. View at Google Scholar
  11. A. Narala and K. Veerabrahma, “Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Volume,” Bioavailability Journal of Pharmaceutics, vol. 2013, Article ID 265741, 7 pages, 2013. View at Publisher · View at Google Scholar
  12. M. Shah and K. Pathak, “Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design,” AAPS PharmSciTech, vol. 11, no. 2, pp. 489–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Aceves-Hernández, J. Hinojosa-Torres, I. Nicolás-Vázquez, R. M. Ruvalcaba, and R. M. L. García, “Solubility of simvastatin: a theoretical and experimental study,” Journal of Molecular Structure, vol. 995, no. 1–3, pp. 41–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Bojjola and L. D. Russell, Electron Microscopy Principles and Techniques for Biologists, Janes and Bartlett publishers, Sudbury, Mass, USA, 2nd edition, 1998.
  15. G. Suresh, K. Manjunath, V. Venkateswarlu, and V. Satyanarayana, “Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles,” AAPS PharmSciTech, vol. 8, no. 1, pp. E162–E170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. K. Venishetty, R. Chede, R. Komuravelli, L. Adepu, R. Sistla, and P. V. Diwan, “Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration,” Colloids and Surfaces B, vol. 95, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Dias Marques-Marinho, B. Diniz Freitas, J. Carlos da Costa Zanon, I. Afonso Reis, A. Alves Lima, and C. Duarte Vianna-Soares, “Development and validation of a RP-HPLC method for simvastatin capsules,” Current Pharma Analysis, vol. 9, no. 1, pp. 2–12, 2013. View at Google Scholar
  18. C. Freitas and R. H. Müller, “Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions,” International Journal of Pharmaceutics, vol. 168, no. 2, pp. 221–229, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Gambhire, M. Bhalekar, and B. Shrivastava, “Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration,” Asian Journal of Pharmaceutical Sciences, vol. 6, no. 6, pp. 251–258, 2011. View at Google Scholar · View at Scopus
  20. C. Bocca, O. Caputo, R. Cavalli, L. Gabriel, A. Miglietta, and M. R. Gasco, “Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 175, no. 2, pp. 185–193, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Martins, I. Thob, I. Reimoldc et al., “Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies,” International Journal of Pharmaceutics, vol. 439, no. 1-2, pp. 49–62, 2012. View at Google Scholar
  22. C. Freitas and R. H. Müller, “Spray-drying of solid lipid nanoparticles (SLNTM),” European Journal of Pharmaceutics and Biopharmaceutics, vol. 46, pp. 145–151, 1998. View at Google Scholar